Skip links

Check out our brand-new oxMIF mechanism of action video

Our team at OncoOne is developing a pipeline of therapeutic antibodies capable of targeting Hashtag#oxMIF, the disease-related isoform of MIF discovered by our founders. Our mission is to leverage our breakthrough discovery and oxMIF’s potential as a target for systemic treatment of rheumatoid arthritis, nephritis, and the tumors of colorectal and lung cancers. For a visualization of our pioneering approach, check out our brand-new mechanism of action video, which also serves as a sneak peek of what to expect from our upcoming website relaunch. Stay tuned! Link to video: https://youtu.be/q608mSJLYJQ?si=SZhuqB34SSAhuHa0

Home